Matthew Reilley, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Seattle Genetics
    Topic: 
    Advisor
    Date added: 
    09/27/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Cicero
    Topic: 
    Advisor
    Date added: 
    09/27/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Cardinal Health
    Topic: 
    Advisor
    Date added: 
    09/27/2023
Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond